Regulation of steroidogenesis in fetal bovine ovaries: differential effects of LH and FSH
            
                  
                        Supplementary Data
                        
                           - Supplementary Figure 1 - 
                              Effects of graded doses of the aromatase inhibitor letrozole (0.25, 0.5, or 5 µM)
                              on the accumulation of estradiol (E2) in cultures of fetal ovarian pieces over 10
                              days. Doses of letrozole were tested without (white bars) or with T+LH+FSH (black
                              bars; testosterone, 0.5 µM; LH and FSH each at 100 ng/ml). Means with no common letters
                              are different (P < 0.05). N = 6 cultures/treatment, 2 from each of 3 fetuses (86 to
                              89 days old). (PDF 15 KB)
                           
- Supplementary Figure 2 - 
                              Accumulation of estradiol (E2) in cultures of fetal ovarian pieces over 10 days in
                              control medium (Con) or with LH, FSH, or LH+FSH (100 ng/ml), each in the absence (open
                              bars) or presence (black bars) of the aromatase inhibitor letrozole (Let; 0.25 µM).
                              Means with no common letters are different (P < 0.05). N = 10 cultures/treatment,
                              2 from each of 5 fetuses (76 to 89 days old). (PDF 14 KB)
                           
 
                 
         
            
               
                  
                  
                     
                        - 
                           
                              	
                                 Published online before print
                                 October 3, 2016,
                                 doi:
                                 10.1530/JME-16-0152
                                 
                              
                                 	    
                                    J Mol Endocrinol
                                    November 1, 2016 
                                    
                                 	    
                                    vol. 57 
                                    
                                    no. 4 
                                    
                                    275-286